183 related articles for article (PubMed ID: 26861999)
1. The anti-proliferative effect of cation channel blockers in T lymphocytes depends on the strength of mitogenic stimulation.
Petho Z; Balajthy A; Bartok A; Bene K; Somodi S; Szilagyi O; Rajnavolgyi E; Panyi G; Varga Z
Immunol Lett; 2016 Mar; 171():60-9. PubMed ID: 26861999
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of KCa3.1 channels mediates adenosine regulation of the motility of human T cells.
Chimote AA; Hajdu P; Kucher V; Boiko N; Kuras Z; Szilagyi O; Yun YH; Conforti L
J Immunol; 2013 Dec; 191(12):6273-80. PubMed ID: 24227782
[TBL] [Abstract][Full Text] [Related]
3. Potassium channel changes of peripheral blood T-lymphocytes from Kazakh hypertensive patients in Northwest China and the inhibition effect towards potassium channels by telmisartan.
Zhang Q; Gou F; Zhang Y; He Y; He J; Peng L; Cheng L; Yuan Q; Zhang G; Huang S
Kardiol Pol; 2016; 74(5):476-488. PubMed ID: 26502942
[TBL] [Abstract][Full Text] [Related]
4. Blockage of K(Ca)3.1 and Kv1.3 channels of the B lymphocyte decreases the inflammatory monocyte chemotaxis.
Zhang S; Wang X; Ju C; Zhu L; Du Y; Gao C
Int Immunopharmacol; 2016 Feb; 31():266-71. PubMed ID: 26795234
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression by N-methyl-D-aspartate receptor antagonists is mediated through inhibition of Kv1.3 and KCa3.1 channels in T cells.
Kahlfuß S; Simma N; Mankiewicz J; Bose T; Lowinus T; Klein-Hessling S; Sprengel R; Schraven B; Heine M; Bommhardt U
Mol Cell Biol; 2014 Mar; 34(5):820-31. PubMed ID: 24344200
[TBL] [Abstract][Full Text] [Related]
6. Regulation of T Lymphocyte Functions through Calcium Signaling Modulation by Nootkatone.
Lee JM; Kim J; Park SJ; Nam JH; Kim HJ; Kim WK
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791278
[TBL] [Abstract][Full Text] [Related]
7. T Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 Blockers.
Fung-Leung WP; Edwards W; Liu Y; Ngo K; Angsana J; Castro G; Wu N; Liu X; Swanson RV; Wickenden AD
PLoS One; 2017; 12(1):e0170102. PubMed ID: 28107393
[TBL] [Abstract][Full Text] [Related]
8. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets.
Orbán C; Bajnok A; Vásárhelyi B; Tulassay T; Toldi G
Cytometry A; 2014 Jul; 85(7):636-41. PubMed ID: 24827427
[TBL] [Abstract][Full Text] [Related]
9. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis.
Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A
Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192
[TBL] [Abstract][Full Text] [Related]
10. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.
Koch Hansen L; Sevelsted-Møller L; Rabjerg M; Larsen D; Hansen TP; Klinge L; Wulff H; Knudsen T; Kjeldsen J; Köhler R
J Crohns Colitis; 2014 Nov; 8(11):1378-91. PubMed ID: 24793818
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in healthy pregnancy and preeclampsia.
Toldi G; Stenczer B; Treszl A; Kollár S; Molvarec A; Tulassay T; Rigó J; Vásárhelyi B
Am J Reprod Immunol; 2011 Feb; 65(2):154-63. PubMed ID: 20649894
[TBL] [Abstract][Full Text] [Related]
12. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
[TBL] [Abstract][Full Text] [Related]
13. K
Veytia-Bucheli JI; Jiménez-Vargas JM; Melchy-Pérez EI; Sandoval-Hernández MA; Possani LD; Rosenstein Y
Cell Commun Signal; 2018 Aug; 16(1):45. PubMed ID: 30107837
[TBL] [Abstract][Full Text] [Related]
14. T-lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in the neonate.
Toldi G; Treszl A; Pongor V; Gyarmati B; Tulassay T; Vásárhelyi B
Int Immunol; 2010 Sep; 22(9):769-74. PubMed ID: 20601376
[TBL] [Abstract][Full Text] [Related]
15. The Ca2+-activated K+ channel of intermediate conductance:a possible target for immune suppression.
Jensen BS; Hertz M; Christophersen P; Madsen LS
Expert Opin Ther Targets; 2002 Dec; 6(6):623-36. PubMed ID: 12472376
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants.
Pegoraro S; Lang M; Dreker T; Kraus J; Hamm S; Meere C; Feurle J; Tasler S; Prütting S; Kuras Z; Visan V; Grissmer S
Bioorg Med Chem Lett; 2009 Apr; 19(8):2299-304. PubMed ID: 19282171
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
Hu L; Pennington M; Jiang Q; Whartenby KA; Calabresi PA
J Immunol; 2007 Oct; 179(7):4563-70. PubMed ID: 17878353
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4
Li H; Zhao JL; Zhang YM; Han SX
Clin Exp Hypertens; 2018; 40(4):303-311. PubMed ID: 29388859
[TBL] [Abstract][Full Text] [Related]
19. Anti-Inflammatory Effect of Licochalcone A via Regulation of ORAI1 and K
Phan HTL; Kim HJ; Jo S; Kim WK; Namkung W; Nam JH
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639190
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences.
Ghanshani S; Wulff H; Miller MJ; Rohm H; Neben A; Gutman GA; Cahalan MD; Chandy KG
J Biol Chem; 2000 Nov; 275(47):37137-49. PubMed ID: 10961988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]